A new BMJ investigation reveals a “revolving door” between FDA officials tasked with regulating COVID-19 vaccines and the companies who manufacture them.
A new BMJ investigation reveals a “revolving door” between FDA officials tasked with regulating COVID-19 vaccines and the companies who manufacture them.